Safety of fixed-dose aspirin - Extended-release dipyridamole in patients with ischemic heart disease

American Journal of Health-System Pharmacy

Volumn 67, Issue 9, 2010, Pages 728-733

  Crown, Natalie ^a   Mysak, Tania ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

Aspirin; Dipyridamole; Myocardial ischemia; Platelet aggregation inhibitors; Stroke; Sustained action medications; Toxicity; Vasodilating agents

Indexed keywords

ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ASPIRIN, DIPYRIDAMOLE DRUG COMBINATION; DIPYRIDAMOLE;

ANGINA PECTORIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STROKE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; DRUG COMBINATION; DRUG TOXICITY; HEART MUSCLE ISCHEMIA; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL;

ASPIRIN; DIPYRIDAMOLE; DRUG COMBINATIONS; DRUG TOXICITY; HUMANS; META-ANALYSIS AS TOPIC; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 77955064969     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp080645     Document Type: Review

References (28)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002; 324:71-86.
2. Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Stroke. 2006; 37:577-617.
3. Adams RJ, Albers G, Alberts MJ et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008; 39:1647-52.
4. Albers GW, Amarenco P, Easton JD et al. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133(suppl):630S-669S. (Pubitemid 351892974)
5. Diener HC, Cunha L, Forbes C et al. The European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996; 143:1-13.
6. Halkes PH, van Gijn J, Kappelle LJ et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006; 367:1665-73.
7. Smith SC, Allen J, Blair SN et al. AHA/ ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation. 2006; 113:2363-79.
8. Fraker TD Jr, Fihn SD, Gibbons RJ et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. Circulation. 2007; 116:2762-72.
9. Antman EM, Hand M, Armstrong PW et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. Circulation. 2008; 117:296-329.
10. Aggrenox (aspirin-extended release dipyridamole) product information. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals; 2009.
11. Iskandrian AS, Heo J, Askenase A et al. Dipyridamole cardiac imaging. Am Heart J. 1988; 115:432-43.
12. Schaper W. Dipyridamole, an underestimated vascular protective drug. Cardiovasc Drugs Ther. 2005; 19:357-63. (Pubitemid 43029821)
13. Kaski JC. Treatment of stable angina pectoris: is there a role for dipyridamole? Eur Heart J. 2001; 22:1762-4.
14. Keltz TN, Innerfield M, Gitler B et al. Dipyridamole-induced myocardial ischemia. JAMA. 1987; 257:1515-6.
15. Vecchi MR, Cataldo G, Belluzzi F et al. Angina pectoris induced by oral administration of dipyridamole. Minerva Cardioangiol. 1990; 38:165-9.
16. Homma S, Collahan RJ, Ammer B et al. Usefulness of oral dipyridamole suspension for stress thallium imaging without exercise in the detection of coronary artery disease. Am J Cardiol. 1986; 57:503-8.
17. Guideri F, Capecchi PL, Acampa M et al. Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole induced ischemia: a stress echocardiographic study. Int J Cardiol. 2002; 83:209-15. (Pubitemid 34564502)
18. Jagathesan R, Rosen SD, Foale RA et al. Effects of long-term oral dipyridamole treatment on coronary microcirculatory function in patients with chronic stable angina: a substudy of the Persantine in Stable Angina (PISA) study. J Cardiovasc Pharmacol. 2006; 48:110-6.
19. Leonardi-Bee J, Bath PM, Bousser MG et al. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke. 2005; 36:162-8.
20. Verro P, Gorelick PB, Nguyen D. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis. Stroke. 2008; 39:1358-63. (Pubitemid 351440719)
21. De Schryver E, Algra A, van Gijn J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. Cochrane Database Syst Rev. 2007; 3:CD00182.
22. Diener HC, Yussuf S, Sacco C et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008; 359:1238-51.
23. Diener HC, Darius H, Bertrand-Hardy JM et al. Cardiac safety in the European Stroke Prevention Study 2 (ESPS-2). Int J Clin Pract. 2001; 55:162-3.
24. Humphreys DM, Street J, Schumacher H et al. Dipyridamole may be used safely in patients with ischemic heart disease. Int J Clin Pract. 2002; 56:121-7. (Pubitemid 34232986)
25. Picano E, on behalf of the PISA (Persantin in Stable Angina) study group. Dipyridamole in chronic stable angina pectoris: a randomized, double blind, placebo-controlled parallel group study. Eur Heart J. 2001; 22:1785-93.
26. Tsuya T, Okada M, Horie H et al. Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris. Am J Cardiol. 1990; 66:275-8.
27. Lette J, Tatum JL, Fraser S et al. Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol. 1995; 2:3-17.
28. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996; 348:1329-39.